Procédés pour le traitement du VHC avec au moins deux agent antiviral à action direct, ribavirin mais sans interferon.

• 收藏
• 分享

专利权人:

Abbvie Inc.

发明人:

申请号：

EP12189198.0

公开号：

EP2583677A2

申请日:

2012.10.19

申请国别(地区):

EP

年份:

2013

代理人:

摘要：

The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to the subject effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), an inhibitor of cytochrome P450 (e.g., ritonavir), and ribavirin.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/